RAPHAEL ISAACS, M.A., M.D., F.A.C.P.; RALPH W. TRIMMER, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The use of "anti-folic acid" preparations in the treatment of leukemia, as described by Farber, Diamond, Mercer, Sylvester and Wolf,1 has made possible the study of the blood of patients with induced "folic acid deficiency." As folic acid appears to stimulate the maturation of "proerythroblasts" (megaloblasts in pernicious anemia), the absence of this substance should be associated with a delay in the maturation of these cells. Since the red blood cells develop their "size," at this stage, they become larger if delayed too long at this period.
The following case of myeloblastic leukemia illustrates the development of macrocytosis and multilobed
ISAACS R, TRIMMER RW. BLOOD CELL CHANGES IN LEUKEMIA DURING AMINOPTERIN THERAPY*. Ann Intern Med. 1951;35:236–239. doi: https://doi.org/10.7326/0003-4819-35-1-236
Download citation file:
Published: Ann Intern Med. 1951;35(1):236-239.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use